The company had reported net loss of Rs 65.97 crore in the April-June quarter of the last fiscal. Panacea Biotech's net sales in Q1, 2013-14 were at Rs 104.46 crore, an increase of 25.70 percent as against Rs 83.10 crore in the year-ago period, the company said in BSE filing.
Also read: Drug pricing policy issue hurting sector's growth: Biocon
Revenue from vaccines in Q1 grew over four fold at Rs 28.04 crore, and revenue from formulations was at Rs 81.58 crore down 0.22 percent.
Overall expenses in the quarter were at Rs 145.72 crore, an increase of 14.43 percent compared with Rs 127.34 crore in the corresponding period last year.
Panacea Biotech scrip closed at Rs 94.50, up 3 percent, on the BSE.
Anda sedang membaca artikel tentang
Panacea Biotech Q1 net loss at Rs 60.92cr
Dengan url
http://harmonisem.blogspot.com/2013/08/panacea-biotech-q1-net-loss-at-rs-6092cr.html?m=0
Anda boleh menyebar luaskannya atau mengcopy paste-nya
Panacea Biotech Q1 net loss at Rs 60.92cr
namun jangan lupa untuk meletakkan link
Panacea Biotech Q1 net loss at Rs 60.92cr
sebagai sumbernya
0 komentar:
Posting Komentar